Literature DB >> 22922449

Do all patients with prosthetic valve endocarditis need surgery?

Saina Attaran1, Andrew Chukwuemeka, Prakash P Punjabi, Jon Anderson.   

Abstract

A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was 'do all patients with prosthetic valve endocarditis need surgery?' Seventeen papers were found using the reported search that represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. These studies compared the outcome and survival between surgically and non-surgically treated patients with prosthetic valve endocarditis. Of these studies, two were prospective observational studies and the rest were retrospective studies. The results of most of these papers were in accordance with the guidelines of the American College of Cardiology and American Heart association. These studies showed that unless a patient is not a surgical candidate, an operation is the treatment of choice in prosthetic valve endocarditis. Surgery should be performed as soon as possible, particularly in haemodynamically unstable patients and those who develop complications such as heart failure, valvular dysfunction, regurgitation/obstruction, dehiscence and annular abscess. In addition to the above indications and cardiac/valvularrelated complications of prosthetic valve endocarditis, infection with Staphylococcus aureus plays an important role in the outcome, and the presence of this micro-organism should be considered an urgent surgical indication in the treatment of prosthetic valve endocarditis. Surgery should be performed before the development of any cerebral or other complications. In contrast, in stable patients with other micro-organisms, particularly those with organisms sensitive to antibiotic treatment who have no structural valvular damage or cardiac complications, surgery can be postponed. The option of surgical intervention can also be revisited if there is a change in response to the treatment. This option is reserved for selected patients only and we conclude that as soon as the diagnosis of prosthetic valve endocarditis is made, cardiac surgeons should be involved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922449      PMCID: PMC3501300          DOI: 10.1093/icvts/ivs372

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  19 in total

1.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

2.  Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience.

Authors:  P Tornos; B Almirante; M Olona; G Permanyer; T González; J Carballo; A Pahissa; J Soler-Soler
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

3.  Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?

Authors:  K Truninger; C H Attenhofer Jost; B Seifert; P R Vogt; F Follath; A Schaffner; R Jenni
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

4.  Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision.

Authors:  M Wolff; S Witchitz; C Chastang; B Régnier; F Vachon
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

5.  Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period.

Authors:  Hector Alonso-Valle; Concepcion Fariñas-Alvarez; Jose Daniel García-Palomo; Jose Manuel Bernal; Rafael Martín-Durán; Jose Francisco Gutiérrez Díez; Jose Manuel Revuelta; M Carmen Fariñas
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07-10       Impact factor: 5.209

6.  Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment.

Authors:  E F Akowuah; W Davies; S Oliver; J Stephens; I Riaz; P Zadik; G Cooper
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

7.  Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy.

Authors:  S B Calderwood; L A Swinski; A W Karchmer; C M Waternaux; M J Buckley
Journal:  J Thorac Cardiovasc Surg       Date:  1986-10       Impact factor: 5.209

8.  Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only.

Authors:  V L Yu; G D Fang; T F Keys; A A Harris; L O Gentry; P C Fuchs; M M Wagener; E S Wong
Journal:  Ann Thorac Surg       Date:  1994-10       Impact factor: 4.330

9.  Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database.

Authors:  C Chirouze; C H Cabell; V G Fowler; N Khayat; L Olaison; J M Miro; G Habib; E Abrutyn; S Eykyn; G R Corey; C Selton-Suty; B Hoen
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

10.  Prosthetic valve endocarditis: management strategies and prognosis: A ten-year analysis in a tertiary care centre in Tunisia.

Authors:  S Rekik; I Trabelsi; A Znazen; I Maaloul; M Hentati; I Frikha; M Ben Jemaa; A Hammami; S Kammoun
Journal:  Neth Heart J       Date:  2009-02       Impact factor: 2.380

View more
  6 in total

Review 1.  Late postoperative prosthetic pulmonary valve endocarditis in a 13-year-old girl with repaired tetralogy of fallot.

Authors:  Michael C O'Brien; Kamal K Pourmoghadam; William M DeCampli
Journal:  Tex Heart Inst J       Date:  2015-06-01

2.  eComment. Early surgery for patients with uncomplicated prosthetic valve endocarditis.

Authors:  Jamil Hajj-Chahine; Christophe Jayle; Hassan Houmaida; Pierre Corbi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12

3.  Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.

Authors:  Catherine Chirouze; François Alla; Vance G Fowler; Daniel J Sexton; G Ralph Corey; Vivian H Chu; Andrew Wang; Marie-Line Erpelding; Emanuele Durante-Mangoni; Nuria Fernández-Hidalgo; Efthymia Giannitsioti; Margaret M Hannan; Tatjana Lejko-Zupanc; José M Miró; Patricia Muñoz; David R Murdoch; Pierre Tattevin; Christophe Tribouilloy; Bruno Hoen
Journal:  Clin Infect Dis       Date:  2014-11-10       Impact factor: 9.079

4.  "A contemporary description of staphylococcus aureus prosthetic valve endocarditis. Differences according to the time elapsed from surgery".

Authors:  Carmen Sáez; Cristina Sarriá; Isidre Vilacosta; Carmen Olmos; Javier López; Pablo Elpidio García-Granja; Cristina Fernández; Carmen de Las Cuevas; Guillermo Reyes; Lourdes Domínguez; Jose Alberto San Román
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 5.  A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?

Authors:  Umberto Benedetto; Cristiano Spadaccio; Federico Gentile; Marc R Moon; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

6.  A case of transcatheter prosthetic aortic valve endocarditis.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Syed Bilal Rizvi; Aravinda Nanjundappa
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.